USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 16, 2022 | Dec 2021 | $-1.22 | - | $-1.06 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 16, 2022 | Dec 2021 | $0.00 | - | $0.00 |
Applied Therapeutics's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 7 | $-4.30 | $-5.09 | $-3.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-4.30 | $-4.28 | $-4.87 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 7 | $5.34M | $820.00K | $14.50M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $-1.16 | - | - |
| Aug 12, 2021 | Jun 2021 | $-1.17 | $-0.99 | 15.38% |
| May 11, 2021 | Mar 2021 | $-1.00 | $-1.00 | 0.02% |
| Mar 18, 2021 | Dec 2020 | $-1.16 | $-1.06 | 8.66% |
| Nov 12, 2020 | Sep 2020 | $-0.89 | $-1.33 | -48.99% |
| Aug 11, 2020 | Jun 2020 | $-0.68 | $-1.27 | -85.75% |
| May 11, 2020 | Mar 2020 | $-0.84 | $-0.59 | 29.48% |
| Mar 13, 2020 | Dec 2019 | $-0.64 | $-1.57 | -145.73% |
| Nov 13, 2019 | Sep 2019 | $-0.44 | $-0.63 | -42.63% |
| Aug 12, 2019 | Jun 2019 | $-0.43 | $-0.60 | -39.89% |
| Jun 21, 2019 | Mar 2019 | $-0.39 | $-0.67 | -71.79% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 18, 2021 | Dec 2020 | $-4.53 | $-4.25 | - |
| Mar 13, 2020 | Dec 2019 | $-3.00 | $-3.47 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 11, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 18, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 12, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 11, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 13, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 13, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 12, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| Jun 21, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 18, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 13, 2020 | Dec 2019 | $0.00 | $0.00 | - |
APLT's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Applied Therapeutics's next quarterly earnings is $-1.22, with a low EPS estimation of $-1.37, and a high estimation of $-0.99.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.22, the last 2 month trend is $-1.27, and the 3 month trend is $-1.34.
Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Applied Therapeutics's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.
Applied Therapeutics's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.
APLT's earnings per share (EPS) was $-4.25, beating the consensus analysts forecast of $-4.53 by -6.18% , and lower than the previous year's EPS (Dec 2019) by 22.48%.
Revenues were $0.00.
The company reported a net income of $-93.96M.
Applied Therapeutics reported a free cash flow of $-78.21M for its fiscal year, compared to $-36.31M a year ago.
The company ended the fiscal year with $2.81M in total debt, an increase of 37.91% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
